Furthermore, Yang et al. provided the evidence that RAC1 is a target of long coding RNAs and microRNAs for the progression of lung cancer, suggesting that RAC1 may be a new target for drug development for cancer patients with high expression levels of RAC1 [17]. The gene discussed is RAC1; the disease is lung carcinoma.